首页> 美国卫生研究院文献>The Journal of Pathology: Clinical Research >Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma
【2h】

Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma

机译:产生粘蛋白的肺腺癌根据共同的遗传特征调节表型:对粘液腺癌和胶体腺癌的重新评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Whether invasive mucinous adenocarcinoma (IMA) and colloid adenocarcinoma (ICA) of the lung represent separate tumour entities, or simply lie within a spectrum of phenotypic variability, is worth investigating. Fifteen ICA, 12 IMA, 9 ALK‐rearranged adenocarcinomas (ALKA), 8 non‐mucinous KRAS‐mutated adenocarcinomas (KRASA) and 9 mucinous breast adenocarcinomas (MBA) were assessed by immunohistochemistry for alveolar (TTF1, cytoplasmic MUC1), intestinal (CDX‐2, MUC2), gastric (membrane MUC1, MUC6), bronchial (MUC5AC), mesenchymal (vimentin), neuroendocrine (chromogranin A, synaptophysin), sex steroid hormone‐related (oestrogen and progesterone receptors), pan‐mucinous (HNF4A) and pan‐epithelial (keratin 7) lineage biomarkers and by targeted next generation sequencing (TNGS) for 50 recurrently altered cancer genes. Unsupervised clustering analysis using molecular features identified cluster 1 (IMA and ICA), cluster 2 (ALKA and KRASA) and cluster 3 (MBA) (p < 0.0001). Cluster 1 showed four histology‐independent sub‐clusters (S1 to S4) pooled by HFN4A and MUC5AC but diversely reacting for TTF1, MUC1, MUC2, MUC6 and CDX2. Sub‐cluster S1 predominantly featured intestinal‐alveolar, S2 gastrointestinal, S3 gastric and S4 alveolar differentiation. In turn, KRASA and ALKA shared alveolar lineage alongside residual MUC5AC expression, with additional focal CDX2 and diffuse vimentin, respectively. A proximal‐to‐distal scheme extending from terminal (TB) and respiratory (RB) bronchioles to alveolar cells was devised, where S3 originated from distal TB (cellular mucinous adenocarcinoma), S2 from proximal RB (secreting mucinous adenocarcinoma), S1 from intermediate RB (mucin lake‐forming colloid adenocarcinoma), S4 from distal RB (colloid alveolar adenocarcinoma), KRASA from juxta‐alveolar RB (KRAS‐mutated non‐mucinous adenocarcinoma) and ALKA from juxta‐bronchial alveolar cells (ALK‐translocated adenocarcinoma). TNGS analysis showed KRAS, LKB1, TP53, APC and CDKN2A mutation predominance. In conclusion, IMA and ICA are basket categories, which likely originate from distinct domains of stem/progenitor cells spatially distributed along bronchioles upon common molecular features and genetic alterations.
机译:肺的浸润性黏液性腺癌(IMA)和胶体腺癌(ICA)是代表单独的肿瘤实体,还是仅位于表型变异性谱内,值得研究。通过免疫组织化学评估了肺泡(TTF1,细胞质MUCX),肠(CD)的15个ICA,12个IMA,9个ALK重排腺癌(ALKA),8个非粘液性KRAS突变腺癌(KRASA)和9个粘液性乳腺腺癌(MBA)。 ‐2,MUC2),胃(膜MUC1,MUC6),支气管(MUC5AC),间充质(波形蛋白),神经内分泌(嗜铬粒蛋白A,突触素),与性类固醇激素有关的(雌激素和孕激素受体),全粘液(HNF4A)和泛上皮(角蛋白7)谱系生物标志物,并通过针对性的下一代测序(TNGS)处理50个反复改变的癌症基因。使用分子特征的无监督聚类分析确定了聚类1(IMA和ICA),聚类2(ALKA和KRASA)和聚类3(MBA)(p <0.0001)。聚类1显示了由HFN4A和MUC5AC汇集的四个与组织学无关的子类(S1至S4),但对TTF1,MUC1,MUC2,MUC6和CDX2的反应不同。亚簇S1主要表现为肠-肺泡,S2胃肠道,S3胃和S4肺泡分化。反过来,KRASA和ALKA与残余MUC5AC表达共享肺泡谱系,分别具有额外的局灶性CDX2和弥散波形蛋白。设计了一种从末梢(TB)和呼吸(RB)细支气管延伸到肺泡细胞的近端到远端方案,其中S3起源于远端TB(细胞粘液腺癌),S2起源于近端RB(分泌性粘液腺癌),S1来自中间RB(粘液形成湖的胶体腺癌),远端RB(胶体肺泡腺癌)的S4,近端肺泡RB(KRAS突变的非粘液腺癌)的KRASA和近端支气管肺泡细胞(ALK易位的腺癌)的ALKA。 TNGS分析显示KRAS,LKB1,TP53,APC和CDKN2A突变占优势。总之,IMA和ICA是篮子类别,可能源自共同的分子特征和遗传改变沿细支气管空间分布的干/祖细胞的不同区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号